Recent Finacing
Recent Raise
ImPact Biotech develops Padeliporfin vascular-targeted photodynamic drug‑device therapy using optical-fiber non‑thermal laser activation for selective ablation of unresectable solid tumors, currently in Phase 3 ENLIGHTED.
